WWM
PPH icon

Western Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Western Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-73,882
Closed -$4.45M – 410
2019
Q4 		$4.45M Buy
+73,882
New +$4.45M 0.67% 33
2019
Q3 		– Sell
-143,061
Closed -$8.37M – 417
2019
Q2 		$8.37M Buy
+143,061
New +$8.28M 1.1% 22

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WI
Wintrust Investments Chicago, Illinois $114M AUM 21.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Western Wealth Management's PPH Position: Q1 2020 in Review

Western Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2020, closing a stake of 73,882 shares — an estimated $4.45M sold.

Western Wealth Management first reported a position in PPH in Q2 2019 and held it in 2 quarters. The position peaked at $8.37M in Q2 2019. 44 funds tracked by Wall St. Rank hold PPH as of Q1 2020.

  • Western Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q1 2020 after selling out during the quarter.
  • Western Wealth Management sold 73,882 VanEck Pharmaceutical ETF shares in Q1 2020, an estimated $4.45M.
  • Western Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q2 2019 and held it in 2 quarters.
  • Western Wealth Management's VanEck Pharmaceutical ETF position peaked at $8.37M in Q2 2019.
  • 44 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2020.

Based on Western Wealth Management's 13F filing for Q1 2020, filed 27 Apr 2020.